Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1987
Technetium-99m diethyldithiocarbamate (DDC): comparison with thallium-201 DDC as an agent for brain imagingJ R Ballinger, B Gerson, K Y Gulenchyn
Cancer Biotherapy & Radiopharmaceuticals|October 21, 2000
In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumorsT Muzzammil, M J Moore, J R Ballinger
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Technetium-99m dithiocarbamates as potential brain agents: evaluation of aliphatic and amine-containing analoguesJ R Ballinger, B Gerson, K Y Gulenchyn
Nuclear Medicine Communications|April 30, 2003
Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour modelsJ R Ballinger, V Hsue, A M Rauth
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumorsJ R Ballinger, T Muzzammil, M J Moore
AJNR. American Journal of Neuroradiology|June 16, 1999
Brain perfusion imaging in asymptomatic patients receiving cyclosporinT N Sheth, M Ichise, W Kucharczyk
American Journal of Surgery|December 1, 1996
Evaluation of single isotope technetium 99M-sestamibi in localization efficiency for hyperparathyroidismD Martin, I B Rosen, M Ichise
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
An introduction to PET and SPECT neuroreceptor quantification modelsM Ichise, J H Meyer, Y Yonekura
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1990
Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brainJ R Ballinger, K Y Gulenchyn, R H Reid
Pageof 12